Bioorganic & Medicinal Chemistry Letters 2006-07-15

Nanomolar inhibition of the enterobactin biosynthesis enzyme, EntE: synthesis, substituent effects, and additivity.

Brian P Callahan, Joseph V Lomino, Richard Wolfenden

Index: Bioorg. Med. Chem. Lett. 16(14) , 3802-5, (2006)

Full Text: HTML

Abstract

2,3-Dihydroxybenzohydroxamoyl adenylate (I) was prepared as a potential product analog inhibitor of EntE (EC# 2.7.7.58), a 2,3-dihydroxybenzoate AMP ligase from Escherichia coli that is required for the biosynthesis of enterobactin. This compound, obtained by the aqueous reaction of imidazole-activated adenosine 5'-phosphate and 2,3-dihydroxybenzohydroxamic acid, is a competitive inhibitor with a Ki value of 4.5 x 10(-9)M. Deletion of the catecholic 3-OH group of (I), in compound (II), reduced inhibitory activity by a factor of 3.5, whereas, removal of both the 3-OH and 2-OH groups, in (III), reduced inhibitory activity by a factor of approximately 2000. Acetohydroxamoyl adenylate (IV), in which the entire catechol moiety of (I) is replaced by a hydrogen atom, gave

Related Compounds

  • Benzohydroxamic ac...

Related Articles:

Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.

2010-03-15

[Bioorg. Med. Chem. 18 , 2225-31, (2010)]

Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.

2007-01-01

[Bioorg. Med. Chem. Lett. 17 , 105-8, (2007)]

Dephosphorylation reactions of mono-, di-, and triesters of 2,4-dinitrophenyl phosphate with deferoxamine and benzohydroxamic acid.

2012-12-07

[J. Org. Chem. 77(23) , 10907-13, (2012)]

Optical spectra of lactoperoxidase as a function of solvent.

2005-12-06

[Biochemistry 44(48) , 15953-9, (2005)]

Inhibition of chymotrypsin by a complex of ortho-vanadate and benzohydroxamic acid: structure of the inert complex and its mechanistic interpretation.

2007-05-22

[Biochemistry 46(20) , 5982-90, (2007)]

More Articles...